Zepteon
Maria Grunwald, Strategic Advisor, is an executive in the life science industry with more than 15 years of experience in business development and licensing. She has held senior roles at Radius Health and Dyax and has gained deep transactional expertise, in particular in strategic partnering. Other companies include AesRx, IsoPlexis, Windgap Medical, Dicerna and QurAlis. In 2009, she was named a mentor for the MIT Venture Mentoring Service. Maria received graduate degrees from the Universities of Hannover and Cologne and performed her Ph.D. studies in neuroscience at the Johns Hopkins University School of Medicine. She also holds an MBA from the MIT Sloan School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Zepteon
Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.